Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2025The Egyptian Journal of Haematology

Acute myeloid leukemia outcome in developing countries: a single center experience as an example in patients aged less than 60 years

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAshraf Z. AbdallaSKSalah KhallafAZAsmaa M. Zahran

Discussion

Loading...

Member takes

Overview

Observational analysis reported poor overall survival and relapse-free survival in AML patients, suggesting urgent need for improvement in care.

Key Points

  • Overall survival was only 2.7 months in patients aged less than 60 with acute myeloid leukemia, highlighting treatment challenges.
  • Objective response rate was observed at 47.3%, yet the prognosis remained poor due to factors like ethnicity and lack of targeted therapy.
  • Assessment involved 93 AML patients using ‘3 + 7’ induction therapy, observing variations in risk stratification outcomes.
  • Major causes of death included infection and bleeding, indicating severe complications during treatment.

Cite This Study

Abdalla et al. (2025) studied this question.

synapsesocial.com/papers/68af6d847567bf4f94fea6bdhttps://doi.org/10.4103/ejh.ejh_89_24
View Full Paper
Ask AI
Bookmark
Share